MedTrace Logo

Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis

NCT01436019 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2011-09-19

No results posted yet for this study

Summary

The purpose of this study is to analyze the frequency of the formation of antibodies against three different anti-TNF biologic agents used for the therapy of juvenile idiopathic arthritis.

Conditions

  • Juvenile Idiopathic Arthritis

Sponsors & Collaborators

  • University Medical Centre Ljubljana

    collaborator OTHER

  • Blood Transfusion Centre of Slovenia

    lead OTHER_GOV

Principal Investigators

  • Miha Kosmač, PhD · Blood Transfusion Centre of Slovenia

  • Tadej Avčin, MD, PhD · University Medical Centre, Ljubljana, Slovenia

  • Vladka Čurin Šerbec, PhD · Blood Transfusion Centre of Slovenia

Eligibility

Min Age
1 Year
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-10-31
Completion
2012-12-31

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01436019 on ClinicalTrials.gov